2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Colonic Polyps
4
Inflammatory Bowel Diseases
3
Surgical Wound Infection
2
Rectal Neoplasms
2
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Sarcoma
1
Polyps
1
Ovarian Neoplasms
1
Opioid-Induced Constipation
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Gastrointestinal Hemorrhage
1
Diverticulitis
1
Colonic Diseases
1
Cancer Pain
1
Adenoma
1
Interventions
Morphine
16
Oxycodone
14
Fentanyl
10
Methadone
7
nabiximols
5
Lidocaine
5
Acetaminophen
5
resiniferatoxin
4
Hydromorphone
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Buprenorphine
3
Transcranial Direct Current Stimulation
2
Tapentadol
2
Surveys and Questionnaires
2
Standard of Care
2
Sodium Bicarbonate
2
Radiosurgery
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Naloxone
2
Ketamine
2
Electroacupuncture
2
Dronabinol
2
Control Groups
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer Pain
×
Polyethylene Glycols
×
Clear all
NCT05216328
2024-11-22
OMAMA
Amsterdam UMC, location VUmc
Phase 4
Recruiting
330 enrolled